申请人:IMPERIAL CHEMICAL INDUSTRIES PLC
公开号:EP0093521A2
公开(公告)日:1983-11-09
Compounds of the formula:-
wherein A stands for the radical -(CH2)2- which may optionally be substituted by one or two (1-2C)alkyl radicals; Q stands for an oxygen or sulphur atom; R° stands for a (1-4C)alkyl, (1-4C)alkoxy or cyclopropyl radical; R' stands for a defined (3-4C)alkyl radical, a phenyl radical which may optionally bear a defined substituent, or a defined heteroaryl radical of 5 to 6 ring atoms; and R2 and R3 stand for hydrogen or a (1-2C)alkyl radical; and pharmaceutically-acceptable acid-addition salts thereof. Processes for the manufacture of said compounds. Pharmaceutical compositions comprising one of said compounds and a pharmaceutical diluent or cerrier. The compounds are 5-hydroxytryptamine antagonists.
式中化合物
其中 A 代表自由基-(CH2)2-,可任选被一个或两个(1-2C)烷基取代;Q 代表氧原子或硫原子;R° 代表(1-4C)烷基、(1-4C)烷氧基或环丙基;R'代表定义的(3-4C)烷基、可任选带有定义取代基的苯基或 5 至 6 个环原子的定义杂芳基;以及 R2 和 R3 代表氢或(1-2C)烷基;及其药学上可接受的酸加成盐。上述化合物的生产工艺。包含上述化合物之一和药用稀释剂或陶瓷载体的药用组合物。所述化合物是5-羟色胺拮抗剂。